Follow
Claus F. Vogelmeier
Claus F. Vogelmeier
Verified email at med.uni-marburg.de
Title
Cited by
Cited by
Year
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
J Vestbo, SS Hurd, AG Agustí, PW Jones, C Vogelmeier, A Anzueto, ...
American journal of respiratory and critical care medicine 187 (4), 347-365, 2013
69482013
Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary
CF Vogelmeier, GJ Criner, FJ Martinez, A Anzueto, PJ Barnes, ...
American journal of respiratory and critical care medicine 195 (5), 557-582, 2017
51642017
Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019
D Singh, A Agusti, A Anzueto, PJ Barnes, J Bourbeau, BR Celli, GJ Criner, ...
European Respiratory Journal 53 (5), 2019
20242019
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18
R Koczulla, G Von Degenfeld, C Kupatt, F Krötz, S Zahler, T Gloe, ...
The Journal of clinical investigation 111 (11), 1665-1672, 2003
11432003
Indacaterol–glycopyrronium versus salmeterol–fluticasone for COPD
JA Wedzicha, D Banerji, KR Chapman, J Vestbo, N Roche, RT Ayers, ...
New England Journal of Medicine 374 (23), 2222-2234, 2016
10742016
Treatable traits: toward precision medicine of chronic airway diseases
A Agusti, E Bel, M Thomas, C Vogelmeier, G Brusselle, S Holgate, ...
European Respiratory Journal 47 (2), 410-419, 2016
10162016
Tiotropium versus salmeterol for the prevention of exacerbations of COPD
C Vogelmeier, B Hederer, T Glaab, H Schmidt, MPMH Rutten-van Mölken, ...
New England Journal of Medicine 364 (12), 1093-1103, 2011
9792011
Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary
A Agustí, BR Celli, GJ Criner, D Halpin, A Anzueto, P Barnes, J Bourbeau, ...
European Respiratory Journal 61 (4), 2023
9592023
Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and chronic obstructive …
DMG Halpin, GJ Criner, A Papi, D Singh, A Anzueto, FJ Martinez, ...
American journal of respiratory and critical care medicine 203 (1), 24-36, 2021
7062021
Symptom variability in patients with severe COPD: a pan-European cross-sectional study
R Kessler, MR Partridge, M Miravitlles, M Cazzola, C Vogelmeier, ...
European Respiratory Journal 37 (2), 264-272, 2011
6122011
An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease
BR Celli, M Decramer, JA Wedzicha, KC Wilson, A Agustí, GJ Criner, ...
American journal of respiratory and critical care medicine 191 (7), e4-e27, 2015
6002015
Identification of a novel, multifunctional β-defensin (human β-defensin 3) with specific antimicrobial activity: its interaction with plasma membranes of Xenopus oocytes and …
JR García, F Jaumann, S Schulz, A Krause, J Rodríguez-Jiménez, ...
Cell and tissue research 306, 257-264, 2001
5962001
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial
H Watz, K Tetzlaff, EFM Wouters, A Kirsten, H Magnussen, ...
The lancet Respiratory medicine 4 (5), 390-398, 2016
5242016
Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease
P Kardos, M Wencker, T Glaab, C Vogelmeier
American journal of respiratory and critical care medicine 175 (2), 144-149, 2007
4702007
Antioxidative and Clinical Effects of High-doseN-Acetylcysteine in Fibrosing Alveolitis: Adjunctive Therapy to Maintenance Immunosuppression
J Behr, K Maier, B Degenkolb, F Krombach, C Vogelmeier
American journal of respiratory and critical care medicine 156 (6), 1897-1901, 1997
4501997
Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised …
CF Vogelmeier, ED Bateman, J Pallante, VKT Alagappan, P D'Andrea, ...
The Lancet Respiratory Medicine 1 (1), 51-60, 2013
4332013
Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study
R Kessler, E Ståhl, C Vogelmeier, J Haughney, E Trudeau, CG Löfdahl, ...
Chest 130 (1), 133-142, 2006
4092006
The discovery of α1-antitrypsin and its role in health and disease
SM Janciauskiene, R Bals, R Koczulla, C Vogelmeier, T Köhnlein, T Welte
Respiratory medicine 105 (8), 1129-1139, 2011
3992011
Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?
C Vogelmeier, A D'Urzo, R Pauwels, JM Merino, M Jaspal, S Boutet, ...
European Respiratory Journal 26 (5), 819-828, 2005
3872005
European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency
M Miravitlles, A Dirksen, I Ferrarotti, V Koblizek, P Lange, R Mahadeva, ...
European Respiratory Journal 50 (5), 2017
3512017
The system can't perform the operation now. Try again later.
Articles 1–20